Stella Diagnostics Stock Price, News & Analysis
Company Description
Stella Diagnostics (OTC Link: SLDX) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $6.4M.
SLDX stock has declined 80.2% over the past year. Shares last traded at $0.0103.
This page provides a comprehensive overview of SLDX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Stella Diagnostics (SLDX) stock last traded at $0.0103. Over the past 12 months, the stock has lost 80.2%. At a market capitalization of $6.4M, SLDX is classified as a micro-cap stock with approximately 301.5M shares outstanding.
Latest News
Stella Diagnostics has 8 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include conferences, management. View all SLDX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Stella Diagnostics (SLDX) currently stands at 125 shares.
Days to Cover History
Days to cover for Stella Diagnostics (SLDX) currently stands at 1.0 days, down 95.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 21.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
SLDX Company Profile & Sector Positioning
Stella Diagnostics (SLDX) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SLDX often look at related companies in the same sector, including Telo Genomics (TDSGF), Avricore Health (AVCRF), Rennova Health (RNVA), Hypha Labs (FUNI), and Imd Companies (ICBU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SLDX's relative position within its industry.